What it's for (Indications)
- This combination medication, comprising triamcinolone acetonide, gentamicin sulfate, and econazole nitrate, is indicated for the topical treatment of various inflammatory dermatoses where secondary bacterial and/or fungal infections are present or are suspected to be present.
- It is particularly useful in managing skin conditions that present with erythema, pruritus, and exudation, such as eczematous dermatitis, contact dermatitis, and intertrigo, complicated by susceptible bacterial organisms (e.
- g.
- , *Staphylococcus aureus*, *Streptococcus pyogenes*) and fungal pathogens (e.
- g.
- , dermatophytes like *Trichophyton* species, *Epidermophyton floccosum*, *Microsporum* species, and yeasts like *Candida albicans*).
- The presence of the corticosteroid (triamcinolone) addresses the inflammatory component, while gentamicin targets bacterial infections, and econazole combats fungal growth.
- Careful clinical assessment is essential to determine the appropriateness of a triple-ingredient product, especially considering the potential for antimicrobial resistance with broad-spectrum agents.
- This preparation is designed for short-term use to resolve acute exacerbations and complex mixed infections, aiming to restore skin integrity and alleviate symptoms efficiently.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | This topical cream or ointment should be applied sparingly to the affected skin area two to three times daily, or as directed by a healthcare professional. A thin film of the medication should be gently massaged into the skin until it disappears. The duration of treatment should generally not exceed two weeks, particularly in areas like the face, groin, and axillae, or in pediatric patients, due to the potential for systemic absorption and local side effects associated with prolonged corticosteroid use. Occlusive dressings should not be used unless specifically instructed by a physician, as they can significantly increase systemic absorption of the corticosteroid component. If there is no improvement in the condition after one week of treatment, or if the condition worsens, the diagnosis and treatment regimen should be re-evaluated by a clinician. Patients should be advised to wash their hands thoroughly before and after applying the medication to prevent further spread of infection or contamination. Discontinuation should be gradual if used for extended periods to avoid rebound phenomena. |
Safety & Warnings
Common Side Effects
- Common side effects associated with the topical application of triamcinolone + gentamicin + econazole typically involve local skin reactions.
- These may include burning, itching, stinging, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
- Due to the gentamicin component, there is a risk of allergic contact dermatitis.
- With econazole, local irritation, erythema, and pruritus can occur.
- Prolonged and extensive use of corticosteroids, especially under occlusion or on large body surface areas, can lead to systemic absorption, potentially resulting in manifestations of Cushing's syndrome, hyperglycemia, and glucosuria, particularly in children.
- Systemic absorption of gentamicin, though rare with topical application on intact skin, can lead to ototoxicity and nephrotoxicity, especially if applied to large areas of denuded skin or in patients with impaired renal function.
- Patients should be counselled to report any severe or persistent adverse reactions to their healthcare provider for evaluation.
Serious Warnings
- Black Box Warning: While this topical combination product does not carry a formal FDA Black Box Warning, clinicians and patients must be fully aware of several serious warnings associated with its use, particularly due to the systemic absorption potential of its components. **Serious Warnings:** Prolonged use, application to large body surface areas, or use under occlusive dressings significantly increases the risk of systemic absorption of triamcinolone acetonide, leading to hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, and other systemic corticosteroid effects. Pediatric patients are particularly susceptible due to a larger skin surface area to body weight ratio. Systemic absorption of gentamicin, though rare with intact skin, can lead to irreversible ototoxicity (hearing loss) and nephrotoxicity (kidney damage) if applied to denuded skin, extensive burns, or for prolonged periods, especially in patients with renal impairment. Corticosteroids can mask the clinical signs of infection, and prolonged use of antibiotics and antifungals can lead to the overgrowth of non-susceptible organisms, including resistant bacteria and fungi, necessitating careful monitoring and appropriate intervention. Patients should be instructed to report any systemic symptoms or local worsening of their condition immediately to their healthcare provider. This product should not be used near the eyes due to the risk of ocular complications, including glaucoma and cataracts.
- Systemic absorption of topical corticosteroids can lead to reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria.
- This risk is increased with the use of more potent corticosteroids, prolonged use, application to large surface areas, use under occlusive dressings, and in pediatric patients.
- Therefore, patients should be periodically evaluated for HPA axis suppression.
- Topical gentamicin absorption, though generally low, may occur, particularly with prolonged use or application to large areas of denuded skin or burns, carrying a theoretical risk of systemic ototoxicity and nephrotoxicity, especially in patients with pre-existing renal impairment or concurrent use of other nephrotoxic/ototoxic drugs.
- Econazole can cause local irritation or allergic reactions.
- This medication is not for ophthalmic use and should not be applied in or near the eyes due to potential for cataracts or glaucoma.
- Discontinue use if irritation, sensitization, or superinfection develops.
- Prolonged use of antibiotics may result in the overgrowth of non-susceptible organisms, including fungi, necessitating appropriate therapy.
- Prolonged use of corticosteroids can mask or exacerbate skin infections, especially fungal infections.
- Pregnant and breastfeeding women should use this product only if clearly needed and after careful consideration of potential risks versus benefits.
How it Works (Mechanism of Action)
This combination medication leverages three distinct pharmacological mechanisms to address inflammatory, bacterial, and fungal components of skin infections. **Triamcinolone acetonide** is a synthetic corticosteroid that exerts potent anti-inflammatory, antipruritic, and vasoconstrictive effects. It works by inducing phospholipase A2 inhibitory proteins, called lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes, thereby reducing inflammation, edema, and itching. **Gentamicin sulfate** is an aminoglycoside antibiotic that acts by irreversibly binding to the 30S ribosomal subunit of susceptible bacteria. This binding interferes with protein synthesis, leading to misreading of the mRNA template and production of non-functional proteins, ultimately resulting in bacterial cell death. It exhibits broad-spectrum activity against many Gram-negative and some Gram-positive organisms. **Econazole nitrate** is a broad-spectrum imidazole antifungal agent. Its primary mechanism of action involves the inhibition of ergosterol synthesis, an essential component of fungal cell membranes. By disrupting ergosterol synthesis, econazole impairs the structural integrity and permeability of the fungal cell membrane, leading to leakage of essential intracellular components and ultimately fungal cell death. Together, these agents provide comprehensive coverage for complex dermatological conditions.
Commercial Brands (Alternatives)
No other brands found for this formula.